Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000030 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 17, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
21,641
Total Value
$363,799.56
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 3,500 | $6.84 | $23,940.00 | 37,518 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 3,500 | $7.80 | $27,300.00 | 41,018 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 16, 2026 | Sale | 2,921 | $40.11 | $117,158.68 | 38,097 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 16, 2026 | Sale | 2,902 | $41.20 | $119,568.78 | 35,195 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 16, 2026 | Sale | 1,177 | $41.94 | $49,358.79 | 34,018 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 16, 2026 | Sale | 641 | $41.30 | $26,473.30 | 33,377 | Direct | โ | View Details | |
Chief Medical Officer | Employee Stock Option (right to buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 214,563 | Direct | โ | View Details | |
Chief Medical Officer | Employee Warrant (right to buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 185,992 | Direct | โ | View Details |